Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2025 · 62 positions · Total reported value $1.49B · Top-10 concentration 53.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.1% · 13 new · 16 cut · 26 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $2.38B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2025 13F filing, Sofinnova Investments, Inc. disclosed 62 equity positions with a combined reported value of $1.49B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were NTRA ($219.23M), SYK ($111.14M), QQQ ($82.06M). By sector, the heaviest allocations are Health Care 81.3%, Industrials 0.8%. Versus the prior quarter, allocation shifted toward Other (+11.4pp) and away from Health Care (-11.7pp).

Versus the prior quarter, Sofinnova Investments, Inc. opened 13 new positions, trimmed 16 and fully exited 26, a turnover rate of 67.1% of positions. The portfolio's overlap with the prior quarter was 56% of names.

The largest new positions opened in Q1 2025 were QQQ ($82.06M), IWM ($69.82M), MDT ($50.59M).

Of the 26 positions fully exited versus the prior quarter, the largest were ABBV ($63.86M), AZN ($42.68M), BSX ($30.96M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • QQQ INVESCO QQQ TR · $82.06M
  • IWM ISHARES TR · $69.82M
  • MDT MEDTRONIC PLC · $50.59M
  • PTCT PTC THERAPEUTICS INC · $29.52M
  • BBIO BRIDGEBIO PHARMA INC · $25.38M
  • BPMC BLUEPRINT MEDICINES CORP · $23.10M
  • BMY BRISTOL-MYERS SQUIBB CO · $22.66M
  • AKRO AKERO THERAPEUTICS INC · $20.65M

Fully Exited (vs previous quarter)

  • ABBV ABBVIE INC · prev qtr: $63.86M
  • AZN ASTRAZENECA PLC · prev qtr: $42.68M
  • BSX BOSTON SCIENTIFIC CORP · prev qtr: $30.96M
  • ALKS ALKERMES PLC · prev qtr: $25.72M
  • GMED GLOBUS MED INC · prev qtr: $20.24M · history
  • JANX JANUX THERAPEUTICS INC · prev qtr: $13.56M
  • NARI INARI MED INC · prev qtr: $9.21M
  • ACHV ACHIEVE LIFE SCIENCE INC · prev qtr: $4.60M

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.3%
Other 17.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.55M $219.23M 14.76%
14.76%
Hold
2 298.57K $111.14M 7.48%
7.48%
Add
3 175.00K $82.06M 5.52%
5.52%
New
4 350.00K $69.82M 4.70%
4.70%
New
5 2.79M $67.11M 4.52%
4.52%
Hold
6 510.05K $63.32M 4.26%
4.26%
Add
7 562.99K $50.59M 3.40%
3.40%
New
8 176.18K $47.57M 3.20%
3.20%
Add
9 418.90K $46.94M 3.16%
3.16%
Reduce
10 52.80K $43.61M 2.94%
2.94%
Add
11 2.62M $42.95M 2.89%
2.89%
Add
12 484.47K $34.62M 2.33%
2.33%
Reduce
13 1.70M $31.37M 2.11%
2.11%
Hold
14 579.34K $29.52M 1.99%
1.99%
New
15 2.28M $27.95M 1.88%
1.88%
Add
16 395.98K $27.04M 1.82%
1.82%
Add
17 734.23K $25.38M 1.71%
1.71%
New
18 2.48M $24.18M 1.63%
1.63%
Reduce
19 446.84K $23.67M 1.59%
1.59%
Add
20 304.25K $23.21M 1.56%
1.56%
Add
21 261.04K $23.10M 1.55%
1.55%
New
22 371.50K $22.66M 1.52%
1.52%
New
23 357.80K $21.66M 1.46%
1.46%
Reduce
24 1.16M $21.57M 1.45%
1.45%
Add
25 327.62K $20.91M 1.41%
1.41%
Reduce
26 510.02K $20.65M 1.39%
1.39%
New
27 175.32K $20.45M 1.38%
1.38%
Add
28 2.00M $20.02M 1.35%
1.35%
Hold
29 520.68K $17.05M 1.15%
1.15%
New
30 5.48M $15.18M 1.02%
1.02%
Hold
31 2.18M $13.07M 0.88%
0.88%
Add
32 1.28M $12.91M 0.87%
0.87%
New
33 58.61K $12.01M 0.81%
0.81%
Add
34 42.94K $11.48M 0.77%
0.77%
New
35 379.93K $11.22M 0.76%
0.76%
Add
36 697.92K $9.76M 0.66%
0.66%
Add
37 2.19M $9.72M 0.65%
0.65%
Hold
38 3.76M $9.43M 0.64%
0.64%
Hold
39 593.40K $9.32M 0.63%
0.63%
Add
40 2.30M $8.67M 0.58%
0.58%
Hold
41 500.00K $8.30M 0.56%
0.56%
New
42 1.04M $8.15M 0.55%
0.55%
New
43 716.90K $7.50M 0.51%
0.51%
Reduce
44 320.40K $7.05M 0.47%
0.47%
Reduce
45 1.55M $7.01M 0.47%
0.47%
Add
46 157.64K $5.97M 0.40%
0.40%
New
47 11.98K $5.94M 0.40%
0.40%
Reduce
48 545.77K $5.79M 0.39%
0.39%
New
49 788.67K $5.31M 0.36%
0.36%
Add
50 791.67K $5.23M 0.35%
0.35%
New

FAQ

What did Sofinnova Investments, Inc. buy in 2025-Q1?

In its 2025-Q1 13F filing, Sofinnova Investments, Inc. reported 62 equity positions worth $1.49B in aggregate; its largest disclosed positions were NTRA ($219.23M), SYK ($111.14M), QQQ ($82.06M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $1.49B of long equity holdings across 62 positions as of 2025-Q1. Top-10 holdings account for 53.9% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →